Lupin LimitedNSE: LUPIN

Press Release Jun 07 2021

· Issued by Lupin Limited

Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2021, titled "Lupin Receives U.S. FDA Approval for Emtricitabine and Tenofovir DisoproxilFumarate Tablets.".

View Attachment